{
    "clinical_study": {
        "@rank": "89128", 
        "arm_group": [
            {
                "arm_group_label": "Rapid diagnostics and probiotic", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Rapid diagnostics and placebo", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Delayed diagnostics and probiotic", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Delayed diagnostics and placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Many children admitted to hospital in Botswana without bloody diarrhoea are presumed to have\n      viral gastroenteritis and so not treated with antibiotics - but they may indeed have a\n      treatable cause for their illness.  We will conduct a randomized trial to see if rapid\n      testing using novel methods to identify potentially treatable causes of diarrhoea leads to\n      improved outcomes.  We will also be randomizing children to probiotic therapy versus placebo\n      (the standard of care) to see if this treatment decreases the duration of diarrhoea.  The\n      proposed study is a pilot trial, necessary before embarking on a large multi-centre trial."
        }, 
        "brief_title": "Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Gastroenteritis", 
        "condition_browse": {
            "mesh_term": "Gastroenteritis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  acute non-bloody gastroenteritis\n\n        Exclusion Criteria:\n\n          -  diarrhoea > 14 days\n\n          -  sepsis, pneumonia, UTI, meningitis, severe metabolic acidosis requiring empiric\n             antibiotic therapy\n\n          -  malignancy, IBD\n\n          -  known link to another patient with diarrhoea of defined aetiology\n\n          -  transferred in already on antimicrobials\n\n          -  live outside study area\n\n          -  children with severe acute malnutrition will be eligible for diagnostic arm but not\n             probiotic arm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Months", 
            "minimum_age": "3 Months"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02025452", 
            "org_study_id": "HHS 13-749"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Rapid diagnostics and probiotic", 
                    "Rapid diagnostics and placebo"
                ], 
                "description": "Specimens from rectal mucosa will be obtained using flocked swabs at enrolment.  Those in 'rapid diagnostic' groups will have them tested using multiplex PCR the day of enrolment and participants with treatable pathogens will have antimicrobials provided.  Those in 'delayed diagnostic' groups will have the swabs batched at tested at the conclusion of the study, being treated as per standard of care.", 
                "intervention_name": "Rapid diagnostic", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Rapid diagnostics and probiotic", 
                    "Delayed diagnostics and probiotic"
                ], 
                "description": "Lactobacillus reuteri, 5 drops/day (1 x 10e8 CFU) x 2 months", 
                "intervention_name": "Probiotic", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "diarrhoea", 
            "gastroenteritis", 
            "rapid diagnostics", 
            "probiotics", 
            "sub-Saharan Africa"
        ], 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "steenhoff@email.chop.edu", 
                "last_name": "Andrew Steenhoff, MBBS, MSc", 
                "phone": "(267) 317 0957"
            }, 
            "facility": {
                "address": {
                    "city": "Gaborone", 
                    "country": "Botswana"
                }, 
                "name": "Princess Marina Hospital"
            }, 
            "investigator": {
                "last_name": "Andrew Steenhoff, MBBS, MSc", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Botswana"
        }, 
        "number_of_arms": "4", 
        "official_title": "Rapid Diagnostics and Probiotic Therapy for Paediatric Acute Gastroenteritis - a Randomized, Factorial, Controlled, Placebo-controlled, Pilot Trial", 
        "overall_official": {
            "affiliation": "McMaster University", 
            "last_name": "Jeffrey Pernica, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "mortality", 
            "safety_issue": "No", 
            "time_frame": "60 days post-enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02025452"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hamilton Health Sciences Corporation", 
            "investigator_full_name": "Jeffrey Pernica", 
            "investigator_title": "Head, Division of Pediatric Infectious Disease", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Height z-score (HAZ) adjusted for initial HAZ", 
                "safety_issue": "No", 
                "time_frame": "60 days post-enrollment"
            }, 
            {
                "measure": "environmental enteropathy score", 
                "safety_issue": "No", 
                "time_frame": "60 days post-enrollment"
            }, 
            {
                "description": "Note that presence of diarrhoea will be checked daily during admission.  Total duration of diarrhoea will be verified with the caregiver by telephone 7 days after the participant was discharged home.", 
                "measure": "duration of diarrhoea", 
                "safety_issue": "No", 
                "time_frame": "estimated average duration ~ 4 days."
            }, 
            {
                "measure": "Weight z-score (WAZ) adjusted for initial WAZ", 
                "safety_issue": "No", 
                "time_frame": "60 days after enrolment"
            }
        ], 
        "source": "Hamilton Health Sciences Corporation", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Grand Challenges Canada", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "BioGaia AB", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Jeffrey Pernica", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}